Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Girolami

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Giornale Italiano Di Cardiologia (2006)|November 24, 2020
[Clinical pathway for cardiomyopathies: a genetic testing strategy proposed by ANMCO in Tuscany]Francesca Girolami, Giuseppe Vergaro, Maurizio Pieroni, et al.
Diagnostics (Basel, Switzerland)|May 16, 2023
Aortic Dilatation in Pediatric Patients with Bicuspid Aortic Valve: How the Choice of Nomograms May Change PrevalenceGaia Spaziani, Francesca Bonanni, Francesca Girolami, et al.
Giornale Italiano Di Cardiologia (2006)|June 30, 2022
[Clinical pathway on pediatric cardiomyopathies: a genetic testing strategy proposed by the Italian Society of Pediatric Cardiology]Francesca Girolami, Maria Iascone, Laura Pezzoli, et al.
Journal of the American College of Cardiology|April 3, 2010
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutationsFrancesca Girolami, Carolyn Y Ho, Christopher Semsarian, et al.
Journal of Clinical Medicine|June 13, 2020
Mitochondrial Energetics and Ca2<sup>+</sup>-Activated ATPase in Obstructive Hypertrophic CardiomyopathyMaria Lombardi, Davide Lazzeroni, Annalinda Pisano, et al.
The American Journal of Cardiology|July 23, 2013
Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathyRossella D'Amato, Benedetta Tomberli, Gabriele Castelli, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 23, 2010
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progressionPaolo Di Donna, Iacopo Olivotto, Sara Dalila Luisella Delcrè, et al.
Circulation. Cardiovascular Genetics|October 8, 2017
Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test InterpretationAisha Furqan, Patricia Arscott, Francesca Girolami, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 28, 2017
Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applicationsFrancesca Girolami, Giulia Frisso, Matteo Benelli, et al.
European Journal of Heart Failure|November 18, 2017
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experienceAlessandra Fornaro, Iacopo Olivotto, Luigi Rigacci, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Giornale Italiano Di Cardiologia (2006)|November 24, 2020
[Clinical pathway for cardiomyopathies: a genetic testing strategy proposed by ANMCO in Tuscany]Francesca Girolami, Giuseppe Vergaro, Maurizio Pieroni, et al.
Diagnostics (Basel, Switzerland)|May 16, 2023
Aortic Dilatation in Pediatric Patients with Bicuspid Aortic Valve: How the Choice of Nomograms May Change PrevalenceGaia Spaziani, Francesca Bonanni, Francesca Girolami, et al.
Giornale Italiano Di Cardiologia (2006)|June 30, 2022
[Clinical pathway on pediatric cardiomyopathies: a genetic testing strategy proposed by the Italian Society of Pediatric Cardiology]Francesca Girolami, Maria Iascone, Laura Pezzoli, et al.
Journal of the American College of Cardiology|April 3, 2010
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutationsFrancesca Girolami, Carolyn Y Ho, Christopher Semsarian, et al.
Journal of Clinical Medicine|June 13, 2020
Mitochondrial Energetics and Ca2<sup>+</sup>-Activated ATPase in Obstructive Hypertrophic CardiomyopathyMaria Lombardi, Davide Lazzeroni, Annalinda Pisano, et al.
The American Journal of Cardiology|July 23, 2013
Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathyRossella D'Amato, Benedetta Tomberli, Gabriele Castelli, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 23, 2010
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progressionPaolo Di Donna, Iacopo Olivotto, Sara Dalila Luisella Delcrè, et al.
Circulation. Cardiovascular Genetics|October 8, 2017
Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test InterpretationAisha Furqan, Patricia Arscott, Francesca Girolami, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 28, 2017
Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applicationsFrancesca Girolami, Giulia Frisso, Matteo Benelli, et al.
European Journal of Heart Failure|November 18, 2017
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experienceAlessandra Fornaro, Iacopo Olivotto, Luigi Rigacci, et al.
Pageof 8